May 29, 2013

The parent company of the Bi-Lo and Winn-Dixie supermarket chains will buy three chains from Belgium-based Delhaize Group.

May 28, 2013

Anglo-Swedish drug maker AstraZeneca will buy Omthera Pharmaceuticals for $323 million, the two companies said.

May 28, 2013

Campbell Soup Co. announced it has entered into an agreement to acquire Plum Organics, a provider of premium organic foods and snacks that serve the nutritional needs of babies, toddlers and children.

May 28, 2013

Canadian drug maker Valeant Pharmaceuticals International is buying U.S.-based Bausch & Lomb Holdings for $8.7 billion, the companies said Monday.

May 22, 2013

Irish drug maker Elan is paying about $380 million to buy two drug makers, the company said.

May 17, 2013

Target is looking to compete with the likes of Netflix and Hulu with a video-streaming service it is beta testing with employees, according to published reports.

May 14, 2013

Actavis is continuing to pursue a plan to buy Irish drug maker Warner Chilcott, as the U.S.-based company announced Tuesday its total number of shares and share-purchase options in order to comply with Ireland's merger-and-acquisition rules.

May 14, 2013

Oscar Mayer announced the addition of five new hot dog innovations featuring bacon, sausage, chicken breast, lean and extra lean varieties available this summer.

May 10, 2013

Actavis is looking into the possibility of buying Warner Chilcott, the generic drug maker said.

May 9, 2013

Cider may be the most exciting new segment in the beer category. A recent report from Mintel indicated that in the United Kingdom, the market penetration of cider is now equal to lager.

May 9, 2013

Meda Consumer Healthcare is quickly developing a reputation for re-energizing iconic brands across new consumer groups. They've done it with Feosol. And now they're looking to reinvent Geritol.

May 3, 2013

Hain Celestial Group, the company that makes Celestial Seasonings tea and other products, has purchased organic baby food company Ella's Kitchen Group, the company said.

May 3, 2013

Healthcare analytics firm IMS Health has acquired social media analytics company Semantelli Corp., saying the purchase would allow it to provide real-time monitoring and delivery of insights into consumer and physician behavior and sentiments.

May 1, 2013

Drug maker Actavis has acquired rights to a treatment for an experimental bacterial vaginosis from Valeant Pharmaceuticals International for about $55 million, the drug makers said.

May 1, 2013

Bayer HealthCare will buy birth-control product maker Conceptus for $1.1 billion, the companies said.

April 29, 2013

A proposal by Canadian drug maker Valeant Pharmaceuticals International to purchase generic drug maker Actavis has fallen through, according to published reports.

April 23, 2013

RadioShack has ended its mobile phone partnership with Target amid slumping sales, the electronics store chain said.

April 21, 2013

It's official. During its most recent quarterly conference call with analysts, CVS Caremark revealed what many had anticipated: Its acquisition of privately held Brazilian drug store chain Drogaria Onofre was complete.

April 16, 2013

The Jean Coutu Group sold 72.5 million of its 178.4 million shares of Rite Aid stock, according to a Securities and Exchange Commission filing Monday and company announcement Tuesday.

April 16, 2013

A former executive of Supervalu has been tapped for a top position at Stater Bros. Markets, the supermarket chain said.

April 15, 2013

The University of Utah's College of Pharmacy has opened a new research organization designed to encourage collaboration and interaction, according to published reports.

April 8, 2013

The Council for Responsible Nutrition on Monday named six new members, including Aurora Algae, Nature’s Sources, Reckitt Benckiser, Sirio Pharma, Watson and international member JJ Health.

April 4, 2013

Swiss drug maker Covis Pharma will buy U.S. rights to five drugs from Sanofi, Covis said.

April 1, 2013

American Greetings greeting card company has agreed to be taken private by a group led by some of its top executives for about $602 million, the company announced.